USANA Health Sciences, Inc.
USNA · FY2025 · Fiscal year ended Jan 3, 2026 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $925M | $854M | +8.3% |
| Operating income | $37.4M | $66.3M | −43.6% |
| Net income | $10.8M | $42.0M | −74.4% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Oct 3, 2026 · filed Nov 12, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $206M | $214M | −3.6% |
| Operating income | −$1.40M | $1.20M | |
| Net income | −$5.60M | −$6.50M | +13.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was USANA Health Sciences's revenue in FY2025?
- $925M in FY2025 (Fiscal year ended Jan 3, 2026), +8.3% vs $854M a year earlier, per its 10-K filed Mar 2026.
- Was USANA Health Sciences profitable in FY2025?
- Yes: net income was $10.8M and operating income $37.4M in FY2025.
- What was USANA Health Sciences's revenue in Q3 2026?
- $206M (−3.6% vs a year earlier), per its Form 10-Q filed Nov 12, 2026.